Johnson and Johnson Newswire (Page 5)

Johnson and Johnson Newswire (Page 5)

Comprehensive Real-Time News Feed for Johnson and Johnson. (Page 5)

Results 81 - 100 of 5,862 in Johnson and Johnson

  1. Rosalynn Carter Institute expands Operation Family Caregiver and...Read the original story w/Photo

    Monday Jul 27 | PRWeb

    The Rosalynn Carter Institute for Caregiving's Operation Family Caregiver will pilot a new volunteer program thanks to funding from the Bristol-Myers Squibb Foundation and a new partnership with Blue Star Families, the largest chapter-based, volunteer, military family engagement organization in the nation.

    Comment?

  2. Women in Business - Meika HollenderRead the original story w/Photo

    Sunday Jul 26 | Financial Times

    Meika Hollender is an MBA graduate of NYU Stern School of Business who used her skills to launch a new brand of sexual health products called Sustain with her father. These include Fair Trade condoms free of toxic chemicals.

    Comment?

  3. Coldwell Banker #3 on list of Best Companies for Work-Life BalanceRead the original story w/Photo

    Sunday Jul 26 | Natl. Relocation & Real Estate

    As Americans in many industries increasingly work longer hours than previous generations and technology continues to facilitate the seepage of work life into home life, companies that prioritize their employees' work-life balance become increasingly attractive. To determine where someone who wants a challenging career and a thriving personal life might find an employer who shares those goals, Forbes turned to job search and company review site Indeed.com to identify some of the best companies for work-life balance.

    Comment?

  4. Allergan To Buy Antidepressant Maker For $560 Million With Hopes Of Preventing SuicidesRead the original story w/Photo

    Sunday Jul 26 | Forbes.com

    Allergan,the drug giant that is famed Botox but also makes antibiotics and an Alzheimer's treatment, will spend $560 million to purchase Naurex, an Evanston, Ill.-based developer of antidepressants that can work in hours, compared to weeks for existing depression pills. The drug giant says it sees opportunity in a depression drug that works in a new way, and hopes the Naurex's experimental medicines might someday be shown to prevent suicidal people from killing themselves.

    Comment?

  5. Alteryx: on a mission to make analysts more productiveRead the original story

    Friday Jul 24 | IT-Director.com

    This month Alteryx, Inc. was in London as a participant of Tableau's user conference. The data blending and advanced analytics vendor has around 350 joint customers with Tableau so it's perhaps no surprise to see the company take prime position at the customer event.

    Comment?

  6. Approval given for 1st hep C type-3 drugRead the original story w/Photo

    Saturday Jul 25 | The China Post

    An experimental drug for one of the hardest-to-treat types of hepatitis C has been approved by the Food and Drug Administration of the U.S., adding to the surge of new options - all much more effective but extremely costly - for patients with the liver-destroying virus. Daklinza, developed by New York-based Bristol-Myers Squibb Co., is the first drug approved to treat genotype 3, the second-most-common form.

    Comment?

  7. Scanning The SA Family For Alpha: SudburyjakesRead the original story w/Photo

    Saturday Jul 25 | Seeking Alpha

    For dividend growth investors, there is a belief that total return does not matter. This may be accurate when sticking to the "hold strategy," but there is more to it.

    Comment?

  8. Entellus Medical's Valuation Doesn't Leave A Lot Of Breathing RoomRead the original story w/Photo

    Friday Jul 24 | Seeking Alpha

    Entellus has developed a slimmer, easier-to-use balloon sinuplasty system that seems well-suited to the underpenetrated in-office sinuplasty market. There is a sharp divide in the ENTs I've spoken to about Entellus and balloon sinuplasty; the supporters find it convenient, safe, and effective, but the skeptics strongly disagree.

    Comment?

  9. AbbVie Sales Fall Short of Estimates as Biggest Drug MissesRead the original story

    Friday Jul 24 | The Washington Post

    Revenue grew 11 percent to $5.48 billion, short of analysts' $5.59 billion prediction, the North Chicago, Illinois- based company said Friday in a statement. Foreign-currency fluctuations hurt sales by 8.3 percent.

    Comment?

  10. Amazon is now worth WAY more than WalmartRead the original story w/Photo

    Friday Jul 24 | KSBW-TV

    Call it a changing of the retail guard. Amazon is worth more than Walmart. A lot more.

    Comment?

  11. Johnson & Johnson Return To Salt Lake CityRead the original story w/Photo

    Thursday Jul 23 | Radio Ink

    Cumulus Media announced that it is bringing back morning team Johnson & Johnson to KUBL/Salt Lake City. The radio duo of Tommy Johnson and Joe Johnson previously enjoyed a 14-year run on the station , before moving to KMPS/Seattle for the past four years.

    Comment?

  12. The horrific Planned Parenthood videos keep coming outRead the original story

    Thursday Jul 23 | WWNC-AM Asheville

    Abortion is a topic most people probably dont want to spend a lot of time thinking about, let alone talking about over lunch. The recent release of a video apparently depicting Planned Parenthood officials eating salad as they haggled and negotiated over the prices of baby partswhile both horrific and bizarreis really not the most serious problem related to the abortion issue.

    Comment?

  13. Korean Biosimilar Companies, A Threat For Big Pharmaceuticals?Read the original story w/Photo

    Thursday Jul 23 | Seeking Alpha

    If you have read David I. Stenberg's book: Korea's Changing Roles in Southeast Asia: Expanding Influence and Relations, you remember this quotation: In the 1970s and 1980s, Korean electronic companies grew to a supplier-oriented industrial upgrading in which producers supplied output to OEM buyers. In the 1990s, Korean companies achieved rapid technological development and became independent producers by establishing their own brands.

    Comment?

  14. 'Johnson & Johnson' returning to country station KBULL 93Read the original story w/Photo

    Thursday Jul 23 | Salt Lake Tribune

    Salt Lake City country station KUBL-FM, better known as KBULL 93 , is bringing back the veteran morning team Johnson & Johnson to their old morning slot, starting Monday. Tommy Johnson and Joe Johnson first came to KBULL 93 in 1997, and worked in the morning slot for 14 years.

    Comment?

  15. Multinational companies take hit on rising U.S. dollarRead the original story w/Photo

    Thursday Jul 23 | The Globe and Mail

    PepsiCo Inc. predicted that foreign exchange will have an "approximate 11-point unfavorable impact on third quarter net revenue growth, and approximate 12-point unfavorable impact on third quarter core [earnings per share] growth." PepsiCo Inc. predicted that foreign exchange will have an "approximate 11-point unfavorable impact on third quarter net revenue growth, and approximate 12-point unfavorable impact on third quarter core [earnings per share] growth."

    Comment?

  16. How to unlock the power of social listeningRead the original story

    Thursday Jul 23 | SmartBrief

    Customers often have great insights on how products are relevant to them, and that's where the real value of social listening lies, writes Peter Friedman. "Social provides a rich, real-time, rejuvenated data source that brands are using to make smarter decisions," he explains.

    Comment?

  17. BioNJ CEO Summit Will Take It To The TopRead the original story

    Wednesday Jul 22 | BioSpace

    Dr. Stephen Ostroff , Acting Commissioner of the Food and Drug Administration , will serve as the featured luncheon speaker at the 3rd Annual BioNJ CEO Summit, Take It to the Top , scheduled for October 9 at the Bridgewater Marriott. Dr. Ostroff will participate in a fireside chat with Dr. William Hait , Global Head of Research and Development for Janssen, the pharmaceutical companies of Johnson & Johnson, entitled: Expediting Therapies and Cures to the Patients Who Need Them: The Evolving Role of the FDA .

    Comment?

  18. Premarket Biotech Digest: The M&A Frenzy, Anavex's Phase 2a Data, Big Day For EarningsRead the original story w/Photo

    Thursday Jul 23 | Seeking Alpha

    Diabetes is unlike any other disease, because it is not an end disease itself, but a cause of multiple diseases - starting from the kidney, to the heart, peripheral organs, and even the brain. The disease occurs when the immune system destroys the pancreas' ability to produce insulin, or the body becomes insulin-resistant, or both.

    Comment?

  19. Athens-Clarke mayor, commissioner argue over water protection recommendationsRead the original story

    Thursday Jul 23 | Athens Banner-Herald

    Athens-Clarke County Commissioner Kelly Girtz's push to revisit a set of recommendations on water resource protection could force the loss of economic development opportunities for the county, Mayor Nancy Denson asserted at a Tuesday commission meeting. The recommendations come from a committee appointed by Denson - and on which Girtz served as chairman - to review buffer requirements for ponds, lakes, wetlands, creeks and rivers.

    Comment?

  20. Retirement Strategy: There Are Dividend Aristocrats That May Be Bad For Your HealthRead the original story w/Photo

    Wednesday Jul 22 | Seeking Alpha

    While a dividend growth investor is reluctant to sell a wonderful dividend payer of elite status, there are times when it makes sense for some portfolios. When the headwinds are blowing right at us, shouldn't the prudent action be to, at the very least, rethink a position? Several months ago, I wrote this article on selling McDonald's from my FMBP because I was not enamored with the poor performance of the company, even though a new CEO was installed and it renewed hopes of finally getting this ship headed in the right direction.

    Comment?